All In Biotech

Drug Trial Radar · NCT05964413

Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

A Randomized, Double-blind, Placebo-controlled, Multicenter, Adaptive Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in the Treatment of Ulcerative Pyoderma Gangrenosum

Last checked: Nov 19, 2026Latest source record: Nov 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

54

Actual

Start

Nov 1, 2023

Primary completion

Jul 11, 2025

Study completion Jul 11, 2025

Sponsor

Lead sponsor
InflaRx GmbHIndustry
Sponsor type
Industry
First posted
Jul 27, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized, double-blind, placebo-controlled, multicenter, adaptive phase III trial to investigate efficacy and safety of vilobelimab in the treatment of ulcerative pyoderma gangrenosum

Conditions

  • Pyoderma Gangrenosum

Interventions

  • vilobelimabDrug

    vilobelimab infusion

  • PlaceboDrug

    Placebo Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of treatment with vilobelimab compared to placeboTime frame: Week 1 to Week 26

Locations

50 sites in 10 countries. Site status is shown where the registry gives one.

  • Aby´s New Generation Research, Inc

    Hialeah, Florida

  • Dermatology/University of Miami Hospital

    Miami, Florida

  • University of Central Florida College of Medicine

    Orlando, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Advanced Medical Research, PC

    Sandy Springs, Georgia

  • Brigham and Women´s Hospital

    Boston, Massachusetts

  • University of North Carolina at Chapel Hill Department of Dermatology

    Chapel Hill, North Carolina

  • Ohio State University Wexner Medical Cente OSU Dermatology West

    Columbus, Ohio

  • Apex Clinical Research Center

    Mayfield Heights, Ohio

  • Oregon Health and Science University

    Portland, Oregon

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • The University of Texas Health Science Center at Houston

    Bellaire, Texas

  • Veracity Clinical Research Pty Ltd as trustee for the MLS Trust

    Brisbane, Australia

  • Liverpool Hospital

    Sydney, Australia

  • Premier Specialists

    Kogarah, NewSouth Wales, Australia

  • The Alfred Hospital, Melbourne

    Melbourne, Victoria, Australia

  • Hôpitaux Universitaires de Bruxelles

    Anderlecht, Belgium

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • Hospital Edouard Herriot

    Lyon, France

  • CHU de Nantes - Clinique dermatologique

    Nantes, France

  • Saint Louis Hospital

    Paris, France

  • CHU Toulouse Hospital Larrey

    Toulouse, Occitanie, France

  • Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany

    Berlin, Germany

  • University clinic Duesseldorf Department of Dermatology Heinrich-Heine-University Duesseldorf

    Düsseldorf, Germany

  • Universitätsklinik für Dermatologie und Venerologie der MLU Halle

    Halle, Germany

  • Universitätsklinikum Hamburg-Eppendorf, Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP)

    Hamburg, Germany

  • University Hospital Leipzig AöR

    Leipzig, Germany

  • Universitätshautklinik Tübingen

    Tübingen, Baden Würrtemberg, Germany

  • Berge Hautklinik

    Erlangen, Bavaria, Germany

  • Universitätsklinikum Heidelberg

    Heidelberg, Bavaria, Germany

  • Klinik und Poliklinik für Dermatologie und Allergologie

    München, Bavaria, Germany

  • University Hospital Würzburg, Department of Dermatology

    Würzburg, Bavaria, Germany

  • Universitätsklinikum Frankfurt, Klinik für Dermatologie

    Frankfurt am Main, Hesse, Germany

  • Catholic Clinic Bochum, Department of Dermatology

    Bochum, Nordrhein-Westfalia, Germany

  • University of Essen, Germany

    Essen, North Rhine-Westphalia, Germany

  • Department of Dermatology, Venerology and Oncodermatology, University of Pécs

    Pécs, Hungary

  • Department of Dermatology and Allergology, University of Szeged

    Szeged, Csongrad-Csanad, Hungary

  • Department of Dermatology, University of Debrecen

    Debrecen, Hadju-Bihar, Hungary

  • IRCCS Policlinico di Sant'Orsola Alma Mater Studiorum - University of Bologna

    Bologna, Italy

  • Fondazione IRCCS Ca´ Granda Ospedale Maggiore Policlinico SC Dermatologia

    Milan, Italy

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.